Pharma/Biotech Stocks to Watch This Prostate Cancer Month

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Oct. 26) read more.....»»

Endocyte licensed a prostate cancer drug a year ago for an upfront payment of $12 million. Now, it’s being bought by the Swiss pharma giant Novartis for more than $2 billion......»»

Drugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma also grows it own cannabis plants......»»

Four pharma/biotech companies are set to release earnings .....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 7) Allakos Inc (NASDAQ: ALLK) BioTelemetry Inc (NASDAQ: BEAT) Emergent Biosolutions Inc (.....»»

Stocks were down in morning trading Friday, putting major indexes on track to snap a three-day winning streak that followed a brutal month of selling. But will next week's earnings results get.....»»

The jobs report comes after U.S. stocks were hammered throughout the month of October......»»

October was a volatile month for the markets, and biotech stocks were no exception. read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week .....»»

October is living up to its reputation as a volatile month for stocks with major indexes down sharply and there is likely more pain ahead for investors, according to one prominent Wall Street analyst......»»

The 2018 European Society for Medical Oncology Congress started Oct. 19 and runs through Oct. 23. Presentations at the congress over the weekend created flutter among stocks of large-cap pharma and biotech companies. read more.....»»

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Biotech stocks.....»»

Drugmakers commonly make their medicines synthetically — think a lab, not a greenhouse. But because its medications employ cannabinoids, the U.K.-based GW Pharma is also involved in agriculture......»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Amid the market mayhem, no biotech or medical device companies made it to 52-week highs. Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 11) read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 8) read more.....»»

If Regeneron Pharmaceuticals NASDAQ REGN Incyte Corporation NASDAQ INCY and AbbVie Inc NYSE ABBV 160 aren t on your list of stocks to consider buying this month you might want to add them These three Motley Fool contributors think new approvals could help.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 1) read more.....»»

Successful drug trials at several biopharmas and FDA approvals make biotech companies a strong investment choice in October October traditionally has been a weak month for stocks. However, biotech stocks have shown significant.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Sept. 25) read more.....»»